Fundamental dimension Equity attribute | ADMAPeer $10.68▼-2.47% Cap $2.39BP/E 14.8x QuantScore77/100 | ABUSLeader $4.20▼-0.24% Cap $832.0MP/E 5.3x QuantScore78/100 | GRFSPeer $7.56▲+1.48% Cap $6.40BP/E 15.6x QuantScore55/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
77/100 |
55/100 |
65/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 75/100 | 98/100 |
Health Piotroski, Altman Z, leverage & liquidity | 89/100 | 90/100 | 40/100 |
Growth Revenue / earnings growth & margins | 52/100 | 80/100 | 38/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 92/100 | 33/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 14.8x | 5.3x | 15.6x |
Forward P/E (next FY) | 13.4x | 5.7x | 8.7x |
EV / EBITDA (TTM) | 10.6x | 5.3x | 8.2x |
Price / Sales | 4.7x | 4.6x | 0.9x |
Price / Free Cash Flow | 20.5x | -33.8x | 8.2x |
PEG ratio | -0.86 | 0.01 | 0.28 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 5 / 9 | 7 / 9 |
Altman Z-Score | 7.67 (Safe) | 30.13 (Safe) | 1.07 (Distress) |
Total debt / equity | 0.50 | 0.01 | 1.54 |
Quick ratio | 3.8x | 81.4x | 0.8x |
Interest coverage | 24.5x | 1937.1x | 2.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +19.6% | +128.2% | +0.2% |
Net income growth YoY | -25.7% | +52.1% | +146.1% |
Gross margin (TTM) | 64.7% | 100.0% | 37.2% |
Operating margin (FY) | 37.5% | -192.1% | 16.4% |
FCF margin (FY) | 5.5% | -281.5% | 10.4% |
5. Trailing price performancePrice change over period |
1M return | +13.9% | -13.9% | +2.9% |
3M return | +29.1% | -4.1% | -0.3% |
6M return | -5.2% | 0.0% | -6.4% |
Year to date | -41.4% | -12.7% | -19.1% |
1Y return | -31.5% | -3.7% | -19.4% |
3Y return | +225.6% | +137.3% | -1.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-110.82 -1137.6% premium | $-2.47 -158.7% premium | $18.81 +148.8% upside |
Wall Street consensus target | $18.67 +74.8% · range $17.00–$21.00 | $8.50 +102.4% · range $8.50–$8.50 | — — |
Consensus stance | 90% Buy10% Hold0% Sell | 80% Buy20% Hold0% Sell | 50% Buy25% Hold25% Sell |